Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Puerto Rico Technology Today.
Press releases published on August 20, 2025
Ascentage Pharma Reports 2025 Interim Unaudited Six Months Financial Results and Business Updates
Product sales from Olverembatinib in the first half of 2025 increased 93% year-over-year to US$30.3 million (RMB217.4 million), primarily attributable to the expansion of NRDL coverage Commenced commercial sales of Lisaftoclax in China, following approval …
Global Enzymes Market Set to Reach $20.4 Billion by 2029 | Asia-Pacific Emerges as a Hotspot
Delray Beach, FL, Aug. 20, 2025 (GLOBE NEWSWIRE) -- According to MarketsandMarkets, the global enzymes market is experiencing robust growth, driven by innovations in biotechnology, increasing demand in biopharmaceutical production, and rising environmental …
NowVertical Group Announces Second Quarter 2025 Earnings Release Date and Financial Update Webinar
TORONTO, Aug. 20, 2025 (GLOBE NEWSWIRE) -- NowVertical Group Inc. (TSXV: NOW) (“NowVertical” or the “Company”), a leading data and AI solutions provider, will announce its 2025 second quarter results after the market close on Wednesday, August 27, 2025. …
Inventronics Announces 2025 Q2 Financial Results
CALGARY, Alberta, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Inventronics Limited (the “Corporation”) (IVX:TSX Venture), a designer and manufacturer of enclosures for the telecommunications, cable, electric distribution, energy, and other industries in Canada and …
Larkspur Biosciences Announces Discovery of LRK-4189, a First-in-Class Degrader of the Lipid Kinase PIP4K2C, for the Treatment of Microsatellite Stable (MSS) Colorectal Cancer at the ACS Fall 2025 Meeting
CAMBRIDGE, Mass., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Larkspur Biosciences, a company pioneering a new wave in cancer therapy that destroys tumors by targeting cancer cell fitness, today announced the discovery of LRK-4189, a first-in-class degrader of the …
BioAge Labs to Present at Upcoming Investor Conferences
EMERYVILLE, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) ("BioAge", "the Company"), a clinical-stage biotechnology company developing therapeutic product candidates for metabolic diseases by targeting the biology of human …
iRhythm Technologies to Participate in Upcoming Investor Conferences
SAN FRANCISCO, Aug. 20, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that its management team is …
Onco360® Has Been Selected as a Specialty Pharmacy Partner for HERNEXEOS® (zongertinib)
LOUISVILLE, K.Y., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a pharmacy partner by Boehringer Ingelheim for Hernexeos® (Zongertinib). The Food and Drug Administration approved …
BlackLine Announces Participation in Upcoming Investor Conference
LOS ANGELES, Aug. 20, 2025 (GLOBE NEWSWIRE) -- BlackLine, Inc. (Nasdaq: BL) today announced that BlackLine’s management team will participate in the following upcoming investor conference: Citi’s 2025 Global TMT Conference Wednesday, September 3, 2025 …
3D Systems Announces Chief Financial Officer Transition
3D Systems’ Executive Vice President, Phyllis Nordstrom to Serve as Interim Chief Financial Officer ROCK HILL, S.C., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Today, 3D Systems (NYSE: DDD) announced that Jeffrey D. Creech is stepping down as the company’s Chief …
Astera Labs Announces Third Quarter 2025 Financial Conference Participation
SAN JOSE, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Astera Labs, Inc. (Nasdaq: ALAB), a leader in semiconductor-based connectivity solutions for rack-scale AI infrastructure, today announced its participation in financial conferences for the third quarter …
Sana Biotechnology Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares
SEATTLE, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (Nasdaq: SANA) (“Sana”), a company focused on changing the possible for patients through engineered cells, today announced that it has closed the sale of 3,358,208 shares of its common …
TruGolf Reports Second Quarter 2025 Financial Results Q2 2025 Sales Grow 11.3% Over Q2 2024
Salt Lake City, Utah, Aug. 20, 2025 (GLOBE NEWSWIRE) -- TruGolf Holdings, Inc. (NASDAQ: TRUG), a leading provider of golf simulator software and hardware, announced today its second quarter 2025 results. The Company reported sales of $4.3 million, up 11.3% …
NurExone Biologic Announces Preclinical Evidence of Structural Repair in Injured Spinal Cord Tissue following ExoPTEN Treatment
TORONTO and HAIFA, Israel, Aug. 20, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) is pleased to announce new preclinical imaging results providing anatomical evidence consistent with …
Rhythm Pharmaceuticals Announces FDA Acceptance of sNDA for Setmelanotide in Acquired Hypothalamic Obesity
– U.S. Food and Drug Administration accepts sNDA for filing with priority review; sets PDUFA goal date of December 20, 2025 -- – European Medicines Agency accepts and validates submission for Type II variation MAA for setmelanotide to treat acquired …
Invivyd Announces Proposed Public Offering of Common Stock
WALTHAM, Mass., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Invivyd) (Nasdaq: IVVD) today announced that it has commenced an underwritten public offering of shares of its common stock. In addition, Invivyd intends to grant the underwriters an option …
CLEAR, an Official TSA PreCheck® Enrollment Provider, Now Enrolling at More Than 190 Staples Stores Across U.S.
NEW YORK, Aug. 20, 2025 (GLOBE NEWSWIRE) -- CLEAR (NYSE: YOU), an authorized TSA PreCheck® enrollment provider, has increased its TSA PreCheck enrollment and renewal locations to more than 190 Staples U.S. retail stores nationwide. CLEAR’s partnership with …
Zealand Pharma major shareholder announcement: Van Herk Investments B.V.
Company announcement – No. 19 / 2025 Zealand Pharma major shareholder announcement: Van Herk Investments B.V. Copenhagen, Denmark, August 20, 2025 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the …
QCI Expands Leadership Depth with Strategic Hires with the VizExplorer Integration
SAN DIEGO, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Quick Custom Intelligence (QCI) today announced that its leadership team has grown significantly through a series of strategic hires in 2024–2025, combined with the successful integration of VizExplorer. …
Rackspace stellt „RAISE“ vor: KI-gesteuerte Sicherheits-Engine, die sich in Echtzeit an Cyber-Bedrohungen anpasst
SAN ANTONIO, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Rackspace Technology® (NASDAQ: RXT), ein führender Anbieter von Hybrid-Cloud- und KI-Lösungen, hat heute wichtige KI-gestützte Verbesserungen am Rackspace Cyber Defense Center (RCDC) angekündigt, einem …